Popular Trials
Stem Cell Therapy
Stem Cell Transplant for Age-Related Macular Degeneration
Recruiting1 awardPhase 1 & 2
Bethesda, Maryland
This trial is testing if it is safe to put cells in people's eyes as a possible future treatment for dry age-related macular degeneration. People who have had "wet" macular degeneration in either eye are not eligible.
Popular Filters
Trials for Age-Related Macular Degeneration Patients
Procedure
OcuMet Beacon for Age-Related Macular Degeneration
Recruiting1 award1 criteria
Madison, Wisconsin
This trial aims to see if stressed cells in the retina match up with areas of disease seen in standard imaging and if these images can help identify potential problem areas before symptoms appear. The main focus is on
Gene Therapy
OCU410 for Age-Related Macular Degeneration
Recruiting1 awardPhase 1 & 2
Bellaire, Texas
This trial tests OCU410, a gene therapy injected into the eye, for patients with severe vision loss due to advanced dry AMD. The treatment uses a virus to deliver helpful genes that may restore normal eye function.
Procedure
Tinlarebant for Age-Related Macular Degeneration
Recruiting1 awardPhase 3
Huntington Beach, California
This trial is testing a new pill called tinlarebant in people with Geographic Atrophy, an eye condition that causes vision loss. The goal is to see if the pill can help slow down or stop the progression of the disease.
Virus Therapy
JNJ-81201887 for Geographic Atrophy Due to Age-Related Macular Degeneration
Recruiting0 awardsPhase 2
Phoenix, Arizona
This trial is testing a new treatment called JNJ-81201887 to see if it can slow down the growth of damaged areas in the eyes of people with geographic atrophy. This condition causes parts of the retina to deteriorate, and the treatment aims to protect the retina and preserve vision.
Stem Cell Therapy
OpRegen for Age-Related Macular Degeneration
Recruiting1 awardPhase 2
Cincinnati, Ohio
This trial is testing OpRegen, a cell injection treatment, in patients with severe vision loss due to age-related macular degeneration. The goal is to see if injecting these cells under the retina can help repair or support damaged eye cells.
Trials for AMD Patients
Procedure
OcuMet Beacon for Age-Related Macular Degeneration
Recruiting1 award1 criteria
Madison, Wisconsin
This trial aims to see if stressed cells in the retina match up with areas of disease seen in standard imaging and if these images can help identify potential problem areas before symptoms appear. The main focus is on
Gene Therapy
OCU410 for Age-Related Macular Degeneration
Recruiting1 awardPhase 1 & 2
Bellaire, Texas
This trial tests OCU410, a gene therapy injected into the eye, for patients with severe vision loss due to advanced dry AMD. The treatment uses a virus to deliver helpful genes that may restore normal eye function.
Procedure
Tinlarebant for Age-Related Macular Degeneration
Recruiting1 awardPhase 3
Huntington Beach, California
This trial is testing a new pill called tinlarebant in people with Geographic Atrophy, an eye condition that causes vision loss. The goal is to see if the pill can help slow down or stop the progression of the disease.
Virus Therapy
JNJ-81201887 for Geographic Atrophy Due to Age-Related Macular Degeneration
Recruiting0 awardsPhase 2
Phoenix, Arizona
This trial is testing a new treatment called JNJ-81201887 to see if it can slow down the growth of damaged areas in the eyes of people with geographic atrophy. This condition causes parts of the retina to deteriorate, and the treatment aims to protect the retina and preserve vision.
Stem Cell Therapy
OpRegen for Age-Related Macular Degeneration
Recruiting1 awardPhase 2
Cincinnati, Ohio
This trial is testing OpRegen, a cell injection treatment, in patients with severe vision loss due to age-related macular degeneration. The goal is to see if injecting these cells under the retina can help repair or support damaged eye cells.
Trials With No Placebo
Procedure
OcuMet Beacon for Age-Related Macular Degeneration
Recruiting1 award1 criteria
Madison, Wisconsin
This trial aims to see if stressed cells in the retina match up with areas of disease seen in standard imaging and if these images can help identify potential problem areas before symptoms appear. The main focus is on
Gene Therapy
OCU410 for Age-Related Macular Degeneration
Recruiting1 awardPhase 1 & 2
Bellaire, Texas
This trial tests OCU410, a gene therapy injected into the eye, for patients with severe vision loss due to advanced dry AMD. The treatment uses a virus to deliver helpful genes that may restore normal eye function.
Stem Cell Therapy
OpRegen for Age-Related Macular Degeneration
Recruiting1 awardPhase 2
Cincinnati, Ohio
This trial is testing OpRegen, a cell injection treatment, in patients with severe vision loss due to age-related macular degeneration. The goal is to see if injecting these cells under the retina can help repair or support damaged eye cells.
Device
SING-IMT for Late-Stage Age-Related Macular Degeneration
Recruiting1 award14 criteria
Pasadena, California
This trial tests a tiny telescope implanted in the eye to help people with severe vision loss from late-stage AMD. The telescope magnifies images to improve vision by using healthy parts of the eye.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.